MarketPeel
Insider Trading Intelligence
Pricing
…
JM

John R. Moore

EWTX
GENERAL COUNSEL · EDGEWISE THERAPEUTICS, INC. · CIK 0001191702
FILING MIX · LIFETIME39%/61%
BUYS
45
SELLS
70
TOTAL VALUE
$4.84M
COMPANIES
1
ACTIVE SINCE
Aug 2021
HOLDINGS NOW
20,157
AVG SELL PX
$13.50
TRADE KIND
SHOWING 115 / 115
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
31 backtested trades · 8 horizons · 4 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by John R. Moore, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d31+48.39%+4.73%-1.43%+6.16%+3.51%2.67
14d31+29.03%+9.43%-0.37%+9.80%+13.70%3.09
30d31+22.58%+28.10%+0.54%+27.56%+29.95%5.16
60d31+25.81%+31.85%+5.29%+26.56%+34.64%4.49
90d31+19.35%+36.50%+3.28%+33.22%+30.49%4.40
180d31+32.26%+19.04%+4.40%+14.64%+19.57%2.42
1y31+29.03%+35.51%+16.00%+19.51%+22.40%1.86
2y31(4 pending)+0.00%+135.86%+43.16%+92.70%+108.38%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
EWTX · 20,157 shares · as of Aug 12, 2026
052,957105,914158,871211,82820222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 45 buys / 70 sellsCOVERAGE · 21 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
6,718——20,157Aug 12, 2026Aug 14, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
99$44.50$4.4K20,116Aug 12, 2026Aug 14, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
5,781——15,995Aug 12, 2026Aug 14, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
59$44.41$2.6K20,215Aug 12, 2026Aug 14, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
65,000——65,000Aug 12, 2026Aug 14, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
5,781——11,563Aug 12, 2026Aug 14, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
2,419$43.80$105.9K17,697Aug 12, 2026Aug 14, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
6,718——22,713Aug 12, 2026Aug 14, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
32,500——32,500Aug 12, 2026Aug 14, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
2,439$43.81$106.8K20,274Aug 12, 2026Aug 14, 2026 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
2,098$13.39$28.1K10,214Aug 12, 2025Aug 14, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
5,781——17,344Aug 12, 2025Aug 14, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
5,781——12,312Aug 12, 2025Aug 14, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
26,875——26,875Aug 12, 2025Aug 14, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
161,250——161,250Aug 12, 2025Aug 14, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
1,930$16.45$31.8K6,531May 2, 2025May 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
5,209——8,461May 1, 2025May 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
5,209——0May 1, 2025May 7, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
20,922$0.71$14.9K24,174Sep 23, 2024Sep 24, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
20,922——41,636Sep 23, 2024Sep 24, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
20,922$27.63$578.1K3,252Sep 23, 2024Sep 24, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
50,000$28.37$1.42M3,252Sep 20, 2024Sep 24, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
50,000——62,558Sep 20, 2024Sep 24, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
50,000$0.71$35.5K53,252Sep 20, 2024Sep 24, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
23,125——23,125Aug 12, 2024Aug 14, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
138,750——138,750Aug 12, 2024Aug 14, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
1,956$18.91$37.0K3,252May 2, 2024May 3, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
5,208——5,209May 1, 2024May 3, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
5,208——5,208May 1, 2024May 3, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
8,029$20.01$160.7K0Feb 9, 2024Feb 9, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
8,029——93,162Feb 9, 2024Feb 9, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
8,029$1.93$15.5K8,029Feb 9, 2024Feb 9, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
3,813$1.93$7.4K3,813Feb 8, 2024Feb 9, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
3,813$20.01$76.3K0Feb 8, 2024Feb 9, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
3,813——101,191Feb 8, 2024Feb 9, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
17,993——105,004Feb 7, 2024Feb 9, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
17,993$20.00$359.9K0Feb 7, 2024Feb 9, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
17,993$1.93$34.7K17,993Feb 7, 2024Feb 9, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
8,497$10.50$89.2K0Dec 27, 2023Dec 28, 2023 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
200,000——200,000Aug 17, 2023Aug 18, 2023 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
1,897$8.90$16.9K6,565May 2, 2023May 3, 2023 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
5,208——10,417May 1, 2023May 3, 2023 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
5,208——8,462May 1, 2023May 3, 2023 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
4,730——122,997Oct 3, 2022Oct 5, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
4,730$9.76$46.2K3,000Oct 3, 2022Oct 5, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
4,730$1.93$9.1K7,730Oct 3, 2022Oct 5, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
4,730——127,727Sep 6, 2022Sep 8, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
4,730$1.93$9.1K7,730Sep 6, 2022Sep 8, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
2,351$10.99$25.8K3,000Sep 6, 2022Sep 8, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
2,379$10.83$25.8K5,351Sep 6, 2022Sep 8, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
200,000——200,000Aug 8, 2022Aug 10, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
4,730$1.93$9.1K7,730Aug 3, 2022Aug 5, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
4,502——112,558Aug 3, 2022Aug 5, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
4,730——132,457Aug 3, 2022Aug 5, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
4,502$0.71$3.2K12,232Aug 3, 2022Aug 5, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
9,232$9.31$85.9K3,000Aug 3, 2022Aug 5, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
1,046$8.54$8.9K3,000Jul 6, 2022Jul 7, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
1,046$1.93$2.0K4,046Jul 6, 2022Jul 7, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
1,046——137,187Jul 6, 2022Jul 7, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
4,502——117,060Jul 5, 2022Jul 7, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
3,684$1.93$7.1K6,684Jul 5, 2022Jul 7, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
8,186$8.35$68.3K3,000Jul 5, 2022Jul 7, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
3,684——138,233Jul 5, 2022Jul 7, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
4,502$0.71$3.2K11,186Jul 5, 2022Jul 7, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
17,570——141,917Jun 21, 2022Jun 21, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
13,508$0.71$9.6K16,508Jun 21, 2022Jun 21, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
13,508——121,562Jun 21, 2022Jun 21, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
17,570$1.93$33.9K34,078Jun 21, 2022Jun 21, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
31,078$7.29$226.7K3,000Jun 21, 2022Jun 21, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
22,127——159,487Jun 17, 2022Jun 21, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
22,127$1.93$42.7K25,127Jun 17, 2022Jun 21, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
22,127$6.62$146.4K3,000Jun 17, 2022Jun 21, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
14,722$1.93$28.4K17,722Jun 16, 2022Jun 21, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
14,722$6.17$90.8K3,000Jun 16, 2022Jun 21, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
14,722——181,614Jun 16, 2022Jun 21, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
585$6.11$3.6K21,075Jun 15, 2022Jun 15, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
585$1.93$1.1K21,660Jun 15, 2022Jun 15, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
585——196,336Jun 15, 2022Jun 15, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
18,075$0.71$12.8K21,075Jun 15, 2022Jun 15, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
18,075$6.11$110.4K3,000Jun 15, 2022Jun 15, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
18,075——135,070Jun 15, 2022Jun 15, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
3,628$0.71$2.6K6,628Jun 14, 2022Jun 15, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
3,628$6.02$21.9K3,000Jun 14, 2022Jun 15, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
3,628——153,145Jun 14, 2022Jun 15, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
4,093$0.71$2.9K7,093Jun 13, 2022Jun 15, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
4,093——156,773Jun 13, 2022Jun 15, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
4,093$6.01$24.6K3,000Jun 13, 2022Jun 15, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
7,125$6.05$43.1K3,000Jun 10, 2022Jun 10, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
7,125$0.71$5.1K10,125Jun 10, 2022Jun 10, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
7,125——160,866Jun 10, 2022Jun 10, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
7,615——167,991Jun 9, 2022Jun 10, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
7,615$6.49$49.4K3,000Jun 9, 2022Jun 10, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
7,615$0.71$5.4K10,615Jun 9, 2022Jun 10, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
12,566$0.71$8.9K15,566Jun 8, 2022Jun 10, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
12,566——175,606Jun 8, 2022Jun 10, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
12,566$6.63$83.4K3,000Jun 8, 2022Jun 10, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
973$6.61$6.4K3,000Jun 7, 2022Jun 7, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
973$1.93$1.9K3,973Jun 7, 2022Jun 7, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
17,150$0.71$12.2K20,150Jun 7, 2022Jun 7, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
17,150——188,172Jun 7, 2022Jun 7, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
973——196,921Jun 7, 2022Jun 7, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
17,150$6.61$113.3K3,000Jun 7, 2022Jun 7, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
13,934$6.03$84.1K3,000Jun 6, 2022Jun 7, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
13,934$1.93$26.9K16,934Jun 6, 2022Jun 7, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
13,934——197,894Jun 6, 2022Jun 7, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
15,230——211,828Jun 3, 2022Jun 7, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
15,230$1.93$29.4K18,230Jun 3, 2022Jun 7, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
15,230$6.05$92.2K3,000Jun 3, 2022Jun 7, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
10,800$7.42$80.1K3,000May 16, 2022May 18, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,625——15,625May 1, 2022May 3, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
5,400——205,322Jan 21, 2022Jan 25, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
5,400$0.71$3.8K12,362Jan 21, 2022Jan 25, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
General Counsel
5,400$0.71$3.8K6,962Dec 28, 2021Dec 28, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
General Counsel
5,400——210,722Dec 28, 2021Dec 28, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
120,000——120,000Aug 17, 2021Aug 19, 2021 ↗View →
Other insiders · EWTX
Loading peer insiders…
About this filer
CIK 0001191702
ROLE
General Counsel
PRIMARY
EWTX
COMPANIES
1
ACTIVE SINCE
Aug 2021
MARKETPEEL · /INSIDER/0001191702DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback